Abstract
Malignant neoplasms of the salivary gland are uncommon entities in which surgical resection of the primary lesion has been accepted as a standard therapeutic option. The efficacy of radiation and systemic chemotherapy has been limited for patients with recurrent, metastatic, or unresectable disease because of unfavorable response rates and the short duration of the response. We treated one patient with recurrent adenoid cystic carcinoma arising from the sublingual gland and one patient with primary adenocarcinoma arising from the parotid gland with transfemoral intraarterial chemotherapy, based on full-dose cisplatin and docetaxel and concurrent external-beam radiotherapy. The doses of cisplatin and docetaxel in the two patients were 80–100 mg/m2 and 10–15 mg/m2, respectively. Docetaxel was infused first, followed by cisplatin. Both patients obtained complete responses. Although complications such as mucositis, anorexia, neutropenia, and ischemic colitis were observed, they were well tolerated and manageable. The concomitant chemoradiotherapy of cisplatin and docetaxel seemed to be a practicable option for patients with recurrent and unresectable salivary gland carcinomas.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
RH Spiro (1986) ArticleTitleSalivary neoplasms: overview of a 35-year experience with 2807 patients Head Neck Surg 8 177–184 Occurrence Handle3744850 Occurrence Handle1:STN:280:BimA3czlvVM%3D
CJ O'Brien SJ Soong GA Herrera et al. (1986) ArticleTitleMalignant salivary tumors – analysis of prognostic factors and survival Head Neck Surg 9 82–92 Occurrence Handle3623942
CH Terhaard H Lubsen I Van der Tweel et al. (2004) ArticleTitleSalivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch Head and Neck Oncology Cooperative Group Head Neck 26 681–693 Occurrence Handle15287035 Occurrence Handle10.1002/hed.10400
AP Venook A Tseng FJ Meyers et al. (1987) ArticleTitleCisplatin, doxorubicin, and 5-fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the Northern California Oncology Group J Clin Oncol 5 951–955 Occurrence Handle3585449 Occurrence Handle1:STN:280:BiiB38rht1Q%3D
L Licitra S Marchini S Spinazze et al. (1991) ArticleTitleCisplatin in advanced salivary gland carcinoma. A phase II study of 25 patients Cancer 68 1874–1877 Occurrence Handle1913539 Occurrence Handle1:STN:280:By2D3crivV0%3D Occurrence Handle10.1002/1097-0142(19911101)68:9<1874::AID-CNCR2820680904>3.0.CO;2-S
M Airoldi F Pedani G Succo et al. (2001) ArticleTitlePhase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignancies Cancer 91 541–547 Occurrence Handle11169936 Occurrence Handle1:CAS:528:DC%2BD3MXhtVKjsLg%3D Occurrence Handle10.1002/1097-0142(20010201)91:3<541::AID-CNCR1032>3.0.CO;2-Y
KT Robbins P Kumar FS Wong et al. (2000) ArticleTitleTargeted chemoradiation for advanced head and neck cancer: analysis of 213 patients Head Neck 22 687–693 Occurrence Handle11002324 Occurrence Handle1:STN:280:DC%2BD3M%2Fjt12ksQ%3D%3D Occurrence Handle10.1002/1097-0347(200010)22:7<687::AID-HED8>3.0.CO;2-W
A Homma Y Furuta F Suzuki et al. (2005) ArticleTitleRapid superselective high-dose cisplatin infusion with concomitant radiotherapy for advanced head and neck cancer Head Neck 27 65–71 Occurrence Handle15459915 Occurrence Handle10.1002/hed.20116
RB Sessions DE Lehane RJH Smith et al. (1982) ArticleTitleIntra-arterial cisplatin treatment of adenoid cystic carcinoma Arch Otolaryngol 108 221–224 Occurrence Handle6280657 Occurrence Handle1:STN:280:Bi2C1c7nvFE%3D
NK Ibrahim AA Sahin RA Dubrow et al. (2000) ArticleTitleColitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer Lancet 355 281–283 Occurrence Handle10675076 Occurrence Handle1:CAS:528:DC%2BD3cXhtlCgsbc%3D Occurrence Handle10.1016/S0140-6736(99)06195-4
H Inohara T Inoue S Akahani et al. (2004) ArticleTitleConcurrent chemo-radiation with cisplatin and docetaxel for advanced head and neck cancer. A phase I study Anticancer Res 24 4135–4140 Occurrence Handle15736464 Occurrence Handle1:CAS:528:DC%2BD2MXitFyltLo%3D
M Airoldi G Fornari F Pedani et al. (2000) ArticleTitlePaclitaxel and carboplatin for recurrent salivary gland malignancies Anticancer Res 20 3781–3783 Occurrence Handle11268454 Occurrence Handle1:CAS:528:DC%2BD3cXovVKisbo%3D
JC Ruzich MC Ciesla JI Clark (2002) ArticleTitleResponse to paclitaxel and carboplatin in metastatic salivary gland cancer: a case report Head Neck 24 406–410 Occurrence Handle11933184 Occurrence Handle10.1002/hed.10034
PB Schiff SB Horwitz (1980) ArticleTitleTaxol stabilizes microtubules in mouse fibroblast cells Proc Natl Acad Sci USA 77 1561–1565 Occurrence Handle6103535 Occurrence Handle1:CAS:528:DyaL3cXktVSnt7g%3D Occurrence Handle10.1073/pnas.77.3.1561
C Hennequin N Giocanti V Favaudon (1996) ArticleTitleInteraction of ionizing radiation with paclitaxel (taxol) and docetaxel (taxotere) in HeLa and SQ20B cells Cancer Res 56 1842–1850 Occurrence Handle8620502 Occurrence Handle1:CAS:528:DyaK28Xitlyks7k%3D
S Maeda T Sugiura Y Saikawa et al. (2004) ArticleTitleDocetaxel enhances the cytotoxicity of cisplatin to gastric cancer cells by modification of intracellular platinum metabolism Cancer Sci 95 679–684 Occurrence Handle15298732 Occurrence Handle1:CAS:528:DC%2BD2cXot1Kisbo%3D Occurrence Handle10.1111/j.1349-7006.2004.tb03329.x
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Maruya, Si., Namba, A., Matsubara, A. et al. Salivary gland carcinoma treated with concomitant chemoradiation with intraarterial cisplatin and docetaxel. Int J Clin Oncol 11, 403–406 (2006). https://doi.org/10.1007/s10147-006-0587-0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10147-006-0587-0